PI3K class IB controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma

International Journal of Cancer

Volumn 130, Issue 11, 2012, Pages 2505-2513

  Dituri, Francesco ^a   Mazzocca, Antonio ^a   Lupo, Luigi ^a   Edling, Charlotte E ^b   Azzariti, Amalia ^c   Antonaci, Salvatore ^a   Falasca, Marco ^b   Giannelli, Gianluigi ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

phosphatidylinositol 3,4,5 trisphosphate; proliferation; signal pathways; tumor progression

Indexed keywords

KI 67 ANTIGEN; P110GAMMA PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P21; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE CHECKPOINT; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CARCINOMA, HEPATOCELLULAR; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CLASS IB PHOSPHATIDYLINOSITOL 3-KINASE; G0 PHASE; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; KI-67 ANTIGEN; LIVER NEOPLASMS;

EID: 84859156758     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26319     Document Type: Article

References (25)

1. Wang GL, Iakova P, Wilde M, Awad S, Timchenko NA,. Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory activity. Genes Dev 2004 Apr 15; 18 (8): 912-25.
2. Engelman JA, Luo J, Cantley LC,. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006 Aug; 7 (8): 606-19.
3. Chen KF, Yeh PY, Yeh KH, Lu YS, Huang SY, Cheng AL,. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells. Cancer Res 2008 Aug 15; 68 (16): 6698-707.
4. Fabregat I,. Dysregulation of apoptosis in hepatocellular carcinoma cells. World J Gastroenterol 2009 Feb 7; 15 (5): 513-20.
5. Cantley LC,. The phosphoinositide 3-kinase pathway. Science 2002 May 31; 296 (5573): 1655-7.
6. Hawkins PT, Anderson KE, Davidson K, Stephens LR,. Signalling through Class I PI3Ks in mammalian cells. Biochem Soc Trans 2006 Nov; 34 (Pt 5): 647-62.
7. Vanhaesebroeck B, Welham MJ, Kotani K, Stein R, Warne PH, Zvelebil MJ, Higashi K, Volinia S, Downward J, Waterfield MD,. P110delta, a novel phos phoinositide 3-kinase in leukocytes. Proc Natl Acad Sci U S A 1997 Apr 29; 94 (9): 4330-5.
8. Saudemont A, Garcon F, Yadi H, Roche-Molina M, Kim N, Segonds-Pichon A, Martin-Fontecha A, Okkenhaug K, Colucci F,. p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease. Proc Natl Acad Sci U S A 2009 Apr 7; 106 (14): 5795-800.
9. Kok K, Geering B, Vanhaesebroeck B,. Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci 2009 Mar; 34 (3): 115-27.
10. Hirsch E, Braccini L, Ciraolo E, Morello F, Perino A,. Twice upon a time: PI3K's secret double life exposed. Trends Biochem Sci 2009 May; 34 (5): 244-8.
11. Samuels Y, Velculescu VE,. Oncogenic mutations of PIK3CA in human cancers. Cell Cycle 2004 Oct; 3 (10): 1221-4.
12. Kang S, Bader AG, Zhao L, Vogt PK,. Mutated PI 3-kinases: cancer targets on a silver platter. Cell Cycle 2005 Apr; 4 (4): 578-81.
13. Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH,. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 2005 Feb 17; 24 (8): 1477-80.
14. Benistant C, Chapuis H, Roche S,. A specific function for phosphatidylinositol 3-kinase alpha (p85alpha-p110alpha) in cell survival and for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in de novo DNA synthesis of human colon carcinoma cells. Oncogene 2000 Oct 19; 19 (44): 5083-90.
15. Knobbe CB, Reifenberger G,. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3′-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol 2003 Oct; 13 (4): 507-18.
16. Sawyer C, Sturge J, Bennett DC, O'Hare MJ, Allen WE, Bain J, Jones GE, Vanhaesebroeck B,. Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta. Cancer Res 2003 Apr 1; 63 (7): 1667-75.
17. Giannelli G, Bergamini C, Fransvea E, Marinosci F, Quaranta V, Antonaci S,. Human Hepatocellular Carcinoma (HCC) Cells Require Both alpha3beta1 Integrin and Matrix Metalloproteinases Activity for Migration and Invasion. Lab Invest 2001 Apr; 81 (4): 613-27.
18. Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S,. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 2005; 129: 1375-83.
19. Guillermet-Guibert J, Bjorklof K, Salpekar A, Gonella C, Ramadani F, Bilancio A, Meek S, Smith AJ, Okkenhaug K, Vanhaesebroeck B,. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. Proc Natl Acad Sci U S A. 2008 Jun 17; 105 (24): 8292-7.
20. Iwanaga R, Ozono E, Fujisawa J, Ikeda MA, Okamura N, Huang Y, Ohtani K,. Activation of the cyclin D2 and cdk6 genes through NF-kappaB is critical for cell-cycle progression induced by HTLV-I Tax. Oncogene 2008 Sep 18; 27 (42): 5635-42.
21. Kang S, Denley A, Vanhaesebroeck B, Vogt PK,. Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phospho-inositide 3-kinase. Proc Natl Acad Sci U S A. 2006 Jan 31; 103 (5): 1289-94.
22. Oda K, Okada J, Timmerman L, Rodriguez-Viciana P, Stokoe D, Shoji K, Taketani Y, Kuramoto H, Knight ZA, Shokat KM, McCormick F,. PIK3CA cooperates with other phosphatidylinositol 3′-kinase pathway mutations to effect oncogenic transformation. Cancer Res 2008 Oct 1; 68 (19): 8127-36.
23. Edling CE, Selvaggi F, Buus R, Maffucci T, Di SP, Friess H, Innocenti P, Kocher HM, Falasca M,. Key Role of Phosphoinositide 3-Kinase class IB in Pancreatic Cancer. Clin Cancer Res 2010 Oct 15; 16 (20): 4928-37.
24. Manning BD, Cantley LC,. AKT/PKB signaling: navigating downstream. Cell 2007 Jun 29; 129 (7): 1261-74.
25. Perino A, Ghigo A, Ferrero E, Morello F, Santulli G, Baillie GS, Damilano F, Dunlop AJ, Pawson C, Walser R, Levi R, Altruda F, et al. Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110gamma. Mol Cell 2011 Apr 8; 42 (1): 84-95.